REFERENCES
- Najafi L, Malek M, Valojerdi AE, Aghili R, Khamseh ME, Fallah AE, Tokhmehchi MR, Behrouz MJ: Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus. J Diabetes Complications 27:459–462, 2013.
- Alves Mde C, Carvalheira JB, Módulo CM, Rocha EM: Tear film and ocular surface changes in diabetes mellitus. Arq Bras Oftalmol 71:6–103, 2008.
- Dogru M, Katakami C, Inoue M: Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 108:586–592, 2001.
- Kaiserman I, Kaiserman N, Nakar S, Vinker S: Dry eye in diabetic patients. Am J Ophthalmol 139:498–503, 2005.
- Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR: Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 8:10, 2008.
- Davi G, Santilli F, Patrono C: Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 28:216–226, 2010.
- Fedor D, Kelley DS: Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12:138–146, 2009.
- Milijanovic B, Trivedi K, Dana M, Gilbard JP, Buring JE, Schaumberg DA: Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82:887–893, 2005.
- Roncone M, Bartlett H, Eperjesi F: Essential fatty acids for dry eye: a review. Cont Lens Anterior Eye 33:49–54, 2010.
- Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP: Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 30:308–314, 2011.
- Kangari H, Eftekhari MH, Sardari S, Hashemi H, Salamzadeh J, Ghassemi-Broumand M, Khabazkhoob M: Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology 120:2191–2196, 2013.
- Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782–787, 2001.
- Pinheiro MN Jr, dos Santos PM, dos Santos RC, Barros Jde N, Passos LF, Cardoso Neto J: [Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjogren's syndrome patients]. Arq Bras Oftalmol 70:649–655, 2007.
- Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806, 1991.
- Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK, and the Clinical Efficacy Assessment Subcommittee of the American College of Physicians: Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med 147:417–422, 2007.
- Nelson JD: Impression cytology. Cornea 7:71–81, 1988.
- Gicquel JJ, Navarre R, Langman ME, Coulon A, Balayre S, Milin S, Mercie M, Rossignol A, Barra A, Levillain PM, Gombert JM, Dighiero P: The use of impression cytology in the follow-up of severe ocular burns. Br J Ophthalmol 91:1160–1164, 2007.
- Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL: Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118:615–621, 2000.
- Goebbels M: Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol 84:19–21, 2000.
- Cermak JM, Papas AS, Sullivan RM, Dana MR, Sullivan DA: Nutrient intake in women with primary and secondary Sjögren's syndrome. Eur J Clin Nutr 57:328–334, 2003.
- Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495–505, 2002.
- McCabe E, Narayanan S: Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry 80:555–566, 2009.
- Erdinest N, Shmueli O, Grossman Y, Ovadia H, Solomon A: Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells. Invest Ophthalmol Vis Sci 53:4396–4406, 2012.
- Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR: Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 126:219–225, 2008.
- Macsai MS: The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc 106:336–356, 2008.
- Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A: Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev (1):CD003205, 2008.